Condition: Chronic Pelvic Pain Syndrome · Sponsor: Corewell Health East
Sacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with suffering from chronic pelvic pain (CPP), through a single device implant procedure.
This description comes directly from the study's public registry record.
Jennifer Giordano, BSN · 248-551-3517 · Jennifer.Giordano@corewellhealth.org
Julie Swanson, BSN · 248-551-3551 · Julie.Swanson2@corewellhealth.org
Always discuss trial participation with your own doctor first.
| Corewell Health William Beaumont University Hospital | Royal Oak, Michigan, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06150599